Redhill Biopharma
RDHL
37 hedge funds and large institutions have $56.8M invested in Redhill Biopharma in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
70% more call options, than puts
Call options by funds: $303K | Put options by funds: $178K
36% more capital invested
Capital invested by funds: $41.7M → $56.8M (+$15.1M)
9% more funds holding
Funds holding: 34 → 37 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$604K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$546K |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$197K |
| 4 |
IIM
Ironwood Investment Management
Boston,
Massachusetts
|
+$131K |
| 5 |
CAM
Claret Asset Management
Montreal,
Quebec, Canada
|
+$94.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$1.59M |
| 2 |
Jane Street
New York
|
-$384K |
| 3 |
Millennium Management
New York
|
-$357K |
| 4 |
Morgan Stanley
New York
|
-$335K |
| 5 |
II
Ibex Investors
Denver,
Colorado
|
-$72.8K |
RDHL Hedge Fund Activity: Q3 2019 in Review
37 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2019, worth a combined $56.8M — up 36% from $41.7M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new RDHL positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 8 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $604K. The largest seller was 683 Capital Management, cutting an estimated $1.59M.
- 37 institutional investors held Redhill Biopharma (RDHL) as of Q3 2019, up from 34 in Q2 2019.
- Funds reported $56.8M of Redhill Biopharma stock for Q3 2019, up 36% quarter-over-quarter.
- 7 funds opened new Redhill Biopharma positions in Q3 2019 and 3 closed out, a net change of +4 holders.
- The largest Redhill Biopharma buyer in Q3 2019 was UBS O'Connor, an estimated $604K added.
- The largest Redhill Biopharma seller in Q3 2019 was 683 Capital Management, an estimated $1.59M sold.
Based on aggregated 13F filings for Q3 2019.